Gastrointestinal Cancer News

The FDA granted marketing approval to the Praxis Extended RAS Panel to detect the presence of 56 specific mutations in RAS genes in tumor tissue of patients with metastatic colorectal cancer.

While the Mediterranean diet has been linked to a reduced risk for colorectal cancer, three key elements of the diet are most important for preventing the development of precancerous polyps, according to new research presented at the ESMO World Congress on Gastrointestinal Cancer.

The United European Gastroenterology organization released a report stating that the average daily alcohol intake was between one and four drinks per person in all 28 European Union states, representing a 21% increased risk for developing digestive cancers.

The FDA cleared the expanded use of the DigniCap Cooling System to reduce hair loss during chemotherapy to include all patients with solid tumors.

In patients with HF, survival outcomes were worse than for those with certain kinds of cancer but better than for those with other kinds, according to findings.

The FDA approved the supplemental biologics license application for panitumumab for the treatment of patients with metastatic colorectal cancer and wild-type RAS, according to the drug’s manufacturer.

New research warrants flexible sigmoidoscopy screening starting at age 40 in average risk individuals given the rising incidence of early-onset colorectal cancer and the left-sided predominance of CRC in these patients, according to a presentation at the American Society of Colon and Rectal Surgeons Annual Scientific Meeting.

The advocacy group Fight Colorectal Cancer and Eli Lilly launched the “Biomarked” campaign to highlight the role biomarkers play in the treatment of colorectal cancer.

Patients with metastatic colorectal cancer with non-V600 mutations to BRAF define a clinically distinct disease subtype with a good prognosis, according to results of a retrospective study.

Former Vice President Joe Biden and his wife, Jill Biden, PhD, launched the Biden Cancer Initiative today.